CA125 reduction as a potential predictive marker of radiological response to neoadjuvant chemotherapy in advanced unresectable endometrial cancer
Journal of Gynecologic Oncology · 2027 · 38
DOI: 10.3802/jgo.2027.38.e59 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2027. Verfasst von Wan Kam Chiu und 11 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective Neoadjuvant chemotherapy (NACT) followed by interval cytoreductive surgery is increasingly used in advanced endometrial cancer patients not amenable for primary surgery. However, validated biomarkers to predict treatment response and surgical outcomes remain lacking.
Zitieren
APA
Chiu, W. K., Lau, L. S. K., Kwok, S. T., Chu, M. M. Y., Li, J. J. X., Cheung, A. N. Y., Ip, P. P. C., Ngu, S. F., Ngan, H. Y. S., Chan, K. K. L., You, B., & Tse, K. Y. (2027). CA125 reduction as a potential predictive marker of radiological response to neoadjuvant chemotherapy in advanced unresectable endometrial cancer. Journal of Gynecologic Oncology, 38. https://doi.org/10.3802/jgo.2027.38.e59
Vancouver
Chiu WK, Lau LSK, Kwok ST, Chu MMY, Li JJX, Cheung ANY, et al. CA125 reduction as a potential predictive marker of radiological response to neoadjuvant chemotherapy in advanced unresectable endometrial cancer. Journal of Gynecologic Oncology. 2027;38. doi:10.3802/jgo.2027.38.e59
BibTeX
@article{Chiu2027,
author = {Chiu, Wan Kam and Lau, Lesley Suk Kwan and Kwok, Shuk Tak and Chu, Mandy Man Yee and Li, Joshua Jing Xi and Cheung, Annie Nga Yin and Ip, Philip Pun Ching and Ngu, Siew Fei and Ngan, Hextan Yuen Sheung and Chan, Karen Kar Loen and You, Benoit and Tse, Ka Yu},
title = {CA125 reduction as a potential predictive marker of radiological response to neoadjuvant chemotherapy in advanced unresectable endometrial cancer},
journal = {Journal of Gynecologic Oncology},
year = {2027},
volume = {38},
doi = {10.3802/jgo.2027.38.e59}
}
EUVIMED